...
首页> 外文期刊>Journal of Pathology: Journal of the Pathological Society of Great Britain and Ireland >Androgen depletion up-regulates cadherin-11 expression in prostate cancer.
【24h】

Androgen depletion up-regulates cadherin-11 expression in prostate cancer.

机译:雄激素耗竭上调前列腺癌中钙黏着蛋白11的表达。

获取原文
获取原文并翻译 | 示例
           

摘要

Men with castration-resistant prostate cancer (PCa) frequently develop metastasis in bone. The reason for this association is unclear. We have previously shown that cadherin-11 (also known as OB-cadherin), a homophilic cell adhesion molecule that mediates osteoblast adhesion, plays a role in the metastasis of PCa to bone. Here, we report that androgen-deprivation therapy up-regulates cadherin-11 expression in PCa. In human PCa specimens, immunohistochemical staining showed that 22/26 (85%) primary PCa tumours from men with castration-resistant PCa expressed cadherin-11. In contrast, only 7/50 (14%) androgen-dependent PCa tumours expressed cadherin-11. In the MDA-PCa-2b xenograft animal model, cadherin-11 was expressed in the recurrent tumours following castration. In the PCa cell lines, there is an inverse correlation between expression of cadherin-11 and androgen receptor (AR), and cadherin-11 is expressed in very low levels or not expressed in AR-positive cell lines, including LNCaP, C4-2B4 and VCaP cells. We showed that AR likely regulates cadherin-11 expression in PCa through an indirect mechanism. Although re-expression of AR in the AR-negative PC3 cells led to the inhibition of cadherin-11 expression, depletion of androgen from the culture medium or down-regulation of AR by RNA interference in the C4-2B4 cells or VCaP cells only produced a modest increase of cadherin-11 expression. Promoter analysis indicated that cadherin-11 promoter does not contain a typical AR-binding element, and AR elicits a modest inhibition of cadherin-11 promoter activity, suggesting that AR does not regulate cadherin-11 expression directly. Together, these results suggest that androgen deprivation up-regulates cadherin-11 expression in prostate cancer, and this may contribute to the metastasis of PCa to bone. Our study suggests that therapeutic strategies that block cadherin-11 expression or function may be considered when applying androgen-ablation therapy. Copyright (c) 2010 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
机译:患有去势抵抗性前列腺癌(PCa)的男性经常发生骨转移。这种关联的原因尚不清楚。先前我们已经表明,钙粘着蛋白11(也称为OB-钙粘着蛋白)是一种介导成骨细胞粘附的同型细胞粘附分子,在PCa转移至骨中发挥作用。在这里,我们报告雄激素剥夺疗法上调PCa中的钙黏着蛋白11表达。在人PCa标本中,免疫组化染色显示,来自去势抵抗性PCa男性的22/26(85%)原发性PCa肿瘤表达钙黏着蛋白11。相反,只有7/50(14%)雄激素依赖性PCa肿瘤表达钙粘着蛋白11。在MDA-PCa-2b异种移植动物模型中,去势后复发的肿瘤中表达钙粘蛋白11。在PCa细胞系中,钙黏着蛋白11和雄激素受体(AR)的表达呈负相关,并且钙黏着蛋白11的表达水平很低或在包括LNCaP,C4-2B4在内的AR阳性细胞系中不表达。和VCaP细胞。我们表明,AR可能通过间接机制调节PCa中的钙黏着蛋白11表达。尽管AR阴性PC3细胞中AR的重新表达导致抑制钙黏着蛋白11的表达,但仅产生了C4-2B4细胞或VCaP细胞中的培养基中雄激素耗竭或RNA干扰引起的AR下调。 cadherin-11表达适度增加。启动子分析表明,钙粘着蛋白11启动子不包含典型的AR结合元件,并且AR引起对钙粘着蛋白11启动子活性的适度抑制,这表明AR并不直接调节钙粘着蛋白11的表达。在一起,这些结果表明雄激素剥夺上调前列腺癌中钙黏着蛋白11的表达,这可能有助于PCa转移到骨骼。我们的研究表明,在应用雄激素消融治疗时,可以考虑使用阻断钙粘蛋白11表达或功能的治疗策略。版权所有(c)2010英国和爱尔兰病理学会。由John Wiley&Sons,Ltd.出版

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号